Tag: CRT 2022
CRT 2022: “Reassuring” two-year outcomes for bicuspid TAVI
Two-year findings from the Low-risk TAVI (LRT) Trial, assessing clinical outcomes after transcat...
CRT 2022: Novel transfemoral mitral valve repair technology wins innovation competition
A novel transcatheter system designed for transfemoral mitral valve repair—the NeoChord Nexus sy...
CRT 2022: COBRA-REDUCE findings do not support routine use of nanocoated stent with short-duration DAPT
Final findings from the COBRA-REDUCE randomised trial assessing 14-day dual antiplatelet therapy...
CRT 2022: Four-year LRT data “support TAVI in low-risk patients”
Four-year data from the LRT—Low Risk TAVR—trial show that transcatheter aortic valve implantatio...
CRT 2022: SURPASS registry shows low rate of adverse events associated with Watchman FLX
Results from a new analysis assessing real-world outcomes with the Watchman FLX (Boston Scientif...
CRT 2022 hears results of animal study of Tria TAVI valve
Results from the first animal study of the Tria transcatheter aortic valve (Foldax) have been pr...
CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years
Final five-year results from the BIOFLOW-V trial, presented during a late-breaking trial session...
